Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

256.16
Delayed Data
As of 3:52pm ET
 -1.25 / -0.49%
Today’s Change
216.45
Today|||52-Week Range
270.00
+12.38%
Year-to-Date
AstraZeneca's Lung Cancer Drug Tagrisso Approved in China
Mar 27 / Zacks.com - Paid Partner Content
Should Value Investors Pick Roche Holding (RHHBY)?
Mar 22 / Zacks.com - Paid Partner Content
Roche's Rituxan Gets 'Breakthrough Therapy' Designation by FDA
Mar 24 / Zacks.com - Paid Partner Content
Inovio (INO) Q4 Loss Wider than Expected; Shares Decline
Mar 16 / Zacks.com - Paid Partner Content
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
Mar 24 / Zacks.com - Paid Partner Content
Celldex (CLDX) Shares Up as Q4 Loss Narrows; Sales Beat
Mar 15 / Zacks.com - Paid Partner Content
Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment
Mar 24 / TheStreet.com - Paid Partner Content